| ŠEBEJOVÁ, Ludmila, Martin ŠRÁMEK, Zuzana JAŠKOVÁ, Jitka MALČÍKOVÁ, Veronika NAVRKALOVÁ, Marek BORSKÝ, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ a Martin TRBUŠEK. TP53 mutations but not ATM mutations associate with higher in vitro resistance of CLL cells to rituximab. In 18th Congress of the European Hematology Association in Haematologica, the hematology journal, Stockholm, Švédsko. 2013. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1114378,
author = {Šebejová, Ludmila and Šrámek, Martin and Jašková, Zuzana and Malčíková, Jitka and Navrkalová, Veronika and Borský, Marek and Doubek, Michael and Mayer, Jiří and Pospíšilová, Šárka and Trbušek, Martin},
booktitle = {18th Congress of the European Hematology Association in Haematologica, the hematology journal, Stockholm, Švédsko},
language = {eng},
title = {TP53 mutations but not ATM mutations associate with higher in vitro resistance of CLL cells to rituximab},
year = {2013}
}
TY - CONF
ID - 1114378
AU - Šebejová, Ludmila - Šrámek, Martin - Jašková, Zuzana - Malčíková, Jitka - Navrkalová, Veronika - Borský, Marek - Doubek, Michael - Mayer, Jiří - Pospíšilová, Šárka - Trbušek, Martin
PY - 2013
TI - TP53 mutations but not ATM mutations associate with higher in vitro resistance of CLL cells to rituximab
ER -
ŠEBEJOVÁ, Ludmila, Martin ŠRÁMEK, Zuzana JAŠKOVÁ, Jitka MALČÍKOVÁ, Veronika NAVRKALOVÁ, Marek BORSKÝ, Michael DOUBEK, Jiří MAYER, Šárka POSPÍŠILOVÁ a Martin TRBUŠEK. TP53 mutations but not ATM mutations associate with higher in vitro resistance of CLL cells to rituximab. In \textit{18th Congress of the European Hematology Association in Haematologica, the hematology journal, Stockholm, Švédsko}. 2013.
|
